An interventional study of Virtual Reality in Primary Dysmenorrhea, Menstrual Pain and Anxiety, sponsored by Tokat Gaziosmanpasa University. Recruiting at 2 sites in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by Tokat Gaziosmanpasa University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 81 studies in Dysmenorrhea with a site in Turkey — 19 open to participants now, 23 under way, none of them phase 3. Dysmenorrhea · Turkey.
Among the 81 studies in Dysmenorrhea with a site in Turkey, this one is the 29th largest by planned enrollment of the 72 interventional ones that give a count, is one of 9 that started in 2026, is one of 70 with no phase, reaches primary completion later than 19 of the 22 other live ones, and was the 81st registered.
432 studies on the registry are indexed under Dysmenorrhea; 108 are open to participants now.
Browse Dysmenorrhea studies →19 of the 81 studies in Dysmenorrhea with a site in Turkey are open now. Recruiting first, the newest first:
Istanbul Medipol University Hospital · Sites in Turkey
Ages 18–30 · Women only
Ankara University · Sites in Turkey
Ages 18–25 · Women only
Nigde Omer Halisdemir University · Sites in Turkey
Ages 18–30 · Women only · Healthy volunteers
Acibadem University · Sites in Turkey
Ages 10–19 · Women only
Havva Betül Bacak · Sites in Turkey
Ages 18–35 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 59 Dysmenorrhea studies recruiting now, 7 (12%) set no upper age limit and 51 (86%) stop at 75 or younger; 12 take children under 18; 20 take healthy volunteers.
This study: 18 Years and older · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
81 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 9 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 68 is close to the median of 62 across 364 interventional studies indexed under Dysmenorrhea.
Median enrollment 60 across the 72 interventional studies, 60 across the 9 observational. Of the 52 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 81 has an industry lead sponsor. The 10 most frequent:
Tokat Gaziosmanpasa University is the lead sponsor of 170 studies on the registry; 38 are open to participants now.
Tokat Gaziosmanpasa University has 3 studies filed under Dysmenorrhea — fewer than ten, so there is no comparison to draw.
2 of the studies in Dysmenorrhea with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06398990Acibadem UniversityThe Effect of Cognitive Exercise Therapy Approach and Yoga in Adolescents With Dysmenorrhoea | 2026-12 |
| NCT07409337Nigde Omer Halisdemir UniversitySelf-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms | 2026-12-15 |
Add all 2 to your calendar (.ics) → With an account.
Among the 81 studies in Dysmenorrhea with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Dysmenorrhea, or painful menstrual periods, is a common condition that can affect daily activities and quality of life. This study aims to evaluate whether using virtual reality (VR) can reduce pain and anxiety in women with primary dysmenorrhea.
Participants will be randomly assigned to either a VR group or a 2D video group. Participants in the VR group will watch a relaxing virtual environment using a VR headset for 20 minutes once a day for three consecutive days. Participants in the 2D video group will watch the same content for the same duration and frequency using a 2D screen, such as a phone, tablet, or computer.
Pain intensity and anxiety levels will be assessed before and after each session during the three-day intervention. The study will compare changes in pain and anxiety between the two groups to evaluate the effect of VR in women with primary dysmenorrhea.
Dysmenorrhea is a common menstrual health problem that may negatively affect physical well-being, psychological status, daily activities, and quality of life. Primary dysmenorrhea occurs in the absence of an underlying pelvic pathology and is commonly characterized by cramping pain during menstruation. Pain associated with dysmenorrhea may also be accompanied by psychological symptoms such as anxiety.
Pharmacological treatments are commonly used to manage dysmenorrhea; however, interest in non-pharmacological approaches has increased because of potential limitations and adverse effects associated with medication use. Virtual reality (VR) is a non-pharmacological and non-invasive approach that may help manage pain by directing attention away from painful stimuli and providing an immersive sensory experience.
The purpose of this randomized controlled trial is to evaluate the effect of a relaxing VR-based intervention on pain intensity and anxiety levels among university students with primary dysmenorrhea. The study will also examine changes in these outcomes across repeated measurements during the three-day intervention period. The findings may contribute to the development of non-pharmacological approaches for managing pain and anxiety associated with primary dysmenorrhea.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will watch the same 20-minute relaxation video on a conventional 2D screen (e.g., tablet, smartphone, or computer) once daily for three consecutive days during the first three days of menstruation. Pain intensity and state anxiety will be assessed immediately before and after each session.
Behavioral: Virtual Reality
Participants will receive a 20-minute relaxation video through a virtual reality (VR) headset once daily for three consecutive days during the first three days of menstruation. Pain intensity and state anxiety will be assessed immediately before and after each session.
Behavioral: Virtual Reality
A 20-minute relaxation video will be presented using a virtual reality (VR) headset. Participants will receive the intervention once daily for three consecutive days during the first three days of menstruation. The VR environment is designed to provide an immersive visual and auditory experience and to direct participants' attention away from menstrual pain.
Visual Analog Scale (VAS)
This is used to quantify certain values that cannot be measured numerically. The two extremes of the parameter being evaluated are marked at either end of a 100 mm line, and the patient is asked to indicate their current status on this line by drawing a mark, placing a dot, or pointing. For pain assessment, "no pain" is written at one end and "severe pain" at the other; the patient then marks their current pain level on the line. The distance from the "no pain" end to the patient's mark represents the level of pain. Evaluation is performed by calculating the mean of the values obtained from the patients.
Time frame: 1-3. days
State Anxiety Inventory (STAI-X)
The State-Trait Anxiety Inventory (STAI) form, developed by Spielberger (1983), is used for adults aged 18-69 and consists of 20 items measuring the intensity of anxiety as an emotional state (state anxiety). Responses on the scale are rated as follows: 1: not at all, 2: somewhat, 3: very much, and 4: completely. If more than three items are left unanswered, the completed form is considered invalid and is not scored. Direct items express negative emotions, while reverse-scored items express positive emotions. During scoring, items with a weight of 1 are converted to 4, and those with a weight of 4 are converted to 1. The state anxiety scale contains ten reverse-scored items: items 1, 2, 5, 8, 10, 11, 15, 16, 19, and 20. Theoretically, the obtained scores range from 20 to 80. A high score indicates a high level of anxiety, while a low score indicates a low level of anxiety (Spielberger, 1983). The scale was adapted for Turkish culture by Öner and Le Compte, and reliability and validity
Time frame: 1-3. days
Plan to share: No — Individual participant data will not be shared with other researchers. De-identified aggregate data will be reported in publications resulting from this study.
No publications or documents are linked to this record.
Ran from Sep 2026 to primary completion in Oct 2026, 1 month.
Of 179 non-industry interventional studies with no phase under Dysmenorrhea, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 16. This study's 1 month is below that.
Counting every sponsor, half of 189 studies reached it within 8 months; a quarter within 3 and three quarters within 17.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tokat Gaziosmanpasa University →